BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 16298178)

  • 1. Prevalence of fractures among the Thalassemia syndromes in North America.
    Vogiatzi MG; Macklin EA; Fung EB; Vichinsky E; Olivieri N; Kwiatkowski J; Cohen A; Neufeld E; Giardina PJ
    Bone; 2006 Apr; 38(4):571-5. PubMed ID: 16298178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in the epidemiology of thalassemia in North America: a new minority disease.
    Vichinsky EP; MacKlin EA; Waye JS; Lorey F; Olivieri NF
    Pediatrics; 2005 Dec; 116(6):e818-25. PubMed ID: 16291734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The changing profile of homozygous beta-thalassemia: demography, ethnicity, and age distribution of current North American patients and changes in two decades.
    Pearson HA; Cohen AR; Giardina PJ; Kazazian HH
    Pediatrics; 1996 Mar; 97(3):352-6. PubMed ID: 8604269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone disease in thalassemia: a frequent and still unresolved problem.
    Vogiatzi MG; Macklin EA; Fung EB; Cheung AM; Vichinsky E; Olivieri N; Kirby M; Kwiatkowski JL; Cunningham M; Holm IA; Lane J; Schneider R; Fleisher M; Grady RW; Peterson CC; Giardina PJ;
    J Bone Miner Res; 2009 Mar; 24(3):543-57. PubMed ID: 18505376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thalassemia.
    Cohen AR; Galanello R; Pennell DJ; Cunningham MJ; Vichinsky E
    Hematology Am Soc Hematol Educ Program; 2004; ():14-34. PubMed ID: 15561674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between bone mineral density and erythropoiesis in Thai children and adolescents with thalassemia syndromes.
    Mahachoklertwattana P; Pootrakul P; Chuansumrit A; Choubtum L; Sriphrapradang A; Sirisriro R; Rajatanavin R
    J Bone Miner Metab; 2006; 24(2):146-52. PubMed ID: 16502122
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thalassemia bone disease: a 19-year longitudinal analysis.
    Wong P; Fuller PJ; Gillespie MT; Kartsogiannis V; Kerr PG; Doery JC; Paul E; Bowden DK; Strauss BJ; Milat F
    J Bone Miner Res; 2014 Nov; 29(11):2468-73. PubMed ID: 24764138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low bone mineral density in adolescents with beta-thalassemia.
    Vogiatzi MG; Autio KA; Mait JE; Schneider R; Lesser M; Giardina PJ
    Ann N Y Acad Sci; 2005; 1054():462-6. PubMed ID: 16339698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoporosis in thalassemia major: an update and the I-CET 2013 recommendations for surveillance and treatment.
    De Sanctis V; Soliman AT; Elsedfy H; Yassin M; Canatan D; Kilinc Y; Sobti P; Skordis N; Karimi M; Raiola G; Galati MC; Bedair E; Fiscina B; El Kholy M;
    Pediatr Endocrinol Rev; 2013 Dec; 11(2):167-80. PubMed ID: 24575552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased prevalence of fractures in inadequately transfused and chelated Indian children and young adults with beta thalassemia major.
    Ekbote V; Padidela R; Khadilkar V; Ramanan V; Maheshwari A; Mughal Z; Kariki EP; Crabtree N; Khadilkar A
    Bone; 2021 Feb; 143():115649. PubMed ID: 32950700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peak bone mineral density, lean body mass and fractures.
    Boot AM; de Ridder MA; van der Sluis IM; van Slobbe I; Krenning EP; Keizer-Schrama SM
    Bone; 2010 Feb; 46(2):336-41. PubMed ID: 19833245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An ICET- A survey on Hypoparathyroidism in Patients with Thalassaemia Major and Intermedia: A preliminary report.
    De Sanctis V; Soliman AT; Canatan D; Elsedfy H; Karimi M; Daar S; Rimawi H; Christou S; Skordis N; Tzoulis P; Sobti P; Kakkar S; Kilinc Y; Khater D; Alyaarubi SA; Kaleva V; Lum SH; Yassin MA; Saki F; Obiedat M; Anastasi S; Galati MC; Raiola G; Campisi S; Soliman N; Elshinawy M; Jaouni SA; Di Maio S; Wali Y; Elhakim IZ; Kattamis C
    Acta Biomed; 2018 Jan; 88(4):435-444. PubMed ID: 29350657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone and body composition of children and adolescents with repeated forearm fractures.
    Goulding A; Grant AM; Williams SM
    J Bone Miner Res; 2005 Dec; 20(12):2090-6. PubMed ID: 16294262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassaemia syndromes in North America.
    Vogiatzi MG; Macklin EA; Trachtenberg FL; Fung EB; Cheung AM; Vichinsky E; Olivieri N; Kirby M; Kwiatkowski JL; Cunningham M; Holm IA; Fleisher M; Grady RW; Peterson CM; Giardina PJ;
    Br J Haematol; 2009 Sep; 146(5):546-56. PubMed ID: 19604241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of bone mineral density in patients with hemoglobin H disease.
    Zarei T; Haghpanah S; Parand S; Moravej H; Dabbaghmanesh MH; Omrani GR; Karimi M
    Ann Hematol; 2016 Aug; 95(8):1329-32. PubMed ID: 27256348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between BMD and biochemical, transfusion and endocrinological parameters in pediatric thalassemic patients.
    Mohseni F; Mohajeri-Tehrani MR; Larijani B; Hamidi Z
    Arch Osteoporos; 2014; 9():174. PubMed ID: 24652076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological and radiological study of Egyptian β-thalassemia intermedia and β-thalassemia major patients: relation to complications and response to therapy.
    Mokhtar GM; Tantawy AA; Adly AA; Ismail EA
    Hemoglobin; 2011; 35(4):382-405. PubMed ID: 21797705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fracture prevalence and relationship to endocrinopathy in iron overloaded patients with sickle cell disease and thalassemia.
    Fung EB; Harmatz PR; Milet M; Coates TD; Thompson AA; Ranalli M; Mignaca R; Scher C; Giardina P; Robertson S; Neumayr L; Vichinsky EP;
    Bone; 2008 Jul; 43(1):162-168. PubMed ID: 18430624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone mineral density in children with moderate to severe atopic dermatitis.
    van Velsen SG; Knol MJ; van Eijk RL; de Vroede MA; de Wit TC; Lam MG; Haeck IM; de Bruin-Weller MS; Bruijnzeel-Koomen CA; Pasmans SG
    J Am Acad Dermatol; 2010 Nov; 63(5):824-31. PubMed ID: 20850893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endocrine function and bone disease during long-term chelation therapy with deferasirox in patients with β-thalassemia major.
    Casale M; Citarella S; Filosa A; De Michele E; Palmieri F; Ragozzino A; Amendola G; Pugliese U; Tartaglione I; Della Rocca F; Cinque P; Nobili B; Perrotta S
    Am J Hematol; 2014 Dec; 89(12):1102-6. PubMed ID: 25197009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.